Vocal Emotion Communication With Cochlear Implants
- Disease/Condition
- Cochlear Hearing Loss
- Drug/Device/Intervention
- Perception of acoustic cues to emotion
- Study type
- Observational
- Intervention type
- behavioral
- Primary sponsor
- Father Flanagan's Boys' Home
- Location
- Tempe,Omaha, United States of America
- Phase
- N/A
- Start date
- Jul 01, 2022
- End date
- Jun 30, 2027
- Enrollment
- 255 participants
Vocal emotion recognition accuracy,Vocal emotion recognition sensitivity,Voice pitch (fundamental frequency) of vocal productions,Intensity of vocal productions,Duration of vocal productions,Identifiability of recorded speech emotions
Patients with hearing loss who use cochlear implants (CIs) show significant deficits and
 strong unexplained intersubject variability in their perception and production of spoken
 emotions in speech. This project will investigate the hypothesis that cue-weighting, or how
 patients utilize the different acoustic cues to emotion, accounts for significant variance in
 emotional communication with CIs. The results will focus on children with CIs, but parallel
 measures in postlingually deaf adults with CIs will be made, ensuring that results of these
 studies benefit social communication by CI patients across the lifespan by informing the
 development of technological innovations and improved clinical protocols.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT05486637
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT05486637 through Pure Global AI's free database. This phase not specified trial is sponsored by Father Flanagan's Boys' Home and is currently Recruiting. The study focuses on Cochlear Hearing Loss. Target enrollment is 255 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.